Insulet, the company behind the Omnipod insulin patch-pump, shared plans for new devices for people with diabetes.
by Integrated Diabetes Services
Key Updates:
- Omnipod 6:
- Planned launch: 2027
- New version of the current Omnipod 5 system
- Still a hybrid closed-loop system (some user input needed)
- Features a smart algorithm that learns from your insulin needs
- Fully Closed-Loop System for Type 2 Diabetes:
- Planned launch: 2028
- Fully automated: you won’t need to enter meals or carbs for insulin doses
- Designed to be easy to use and accessible
- Focuses first on people who use both basal and mealtime insulin, with plans to expand to basal-only users
Other Updates:
- Omnipod 5 will get a lower target range next year and connect with all major continuous glucose monitors (CGMs), including the Libre 3 Plus
- A new data platform for users and healthcare providers is also planned
- After FDA approval last year, Insulet is expanding access for people with Type 2 diabetes
Why It Matters:
- These devices aim to make managing diabetes easier and more automated
- People with Type 2 diabetes will benefit from less manual input for insulin doses
- Omnipod 6 will help improve outcomes for users with smarter, personalized insulin delivery
Timeline:
- 2025: Current sales of Omnipod devices continue to grow
- 2027: Omnipod 6 launch
- 2028: Fully closed-loop system for Type 2 diabetes launch
Reuter, E. (2025, November 24). Insulet unveils plans for new diabetes devices. MedTech Dive.
